Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
31,563
Total Claims
$709K
Drug Cost
290
Beneficiaries
$2,443
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
+73%
Cost per patient vs peers
$2,443 vs $1,411 avg
-44%
Brand preference vs peers
6.0% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
19
Opioid Claims
$1,569
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,894 claims · $384K
Generic: 29,652 claims · $321K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 544 | $88K |
| Mirabegron | 158 | $27K |
| Semaglutide | 27 | $27K |
| Rifaximin | 18 | $27K |
| Rivaroxaban | 97 | $16K |
| Gabapentin | 1,497 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $14K |
| Atorvastatin Calcium | 1,996 | $14K |
| Mirtazapine | 1,085 | $13K |
| Risperidone Microspheres | 20 | $13K |
| Pantoprazole Sodium | 1,305 | $12K |
| Potassium Chloride | 691 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $9,416 |
| Fluticasone/Vilanterol | 19 | $8,110 |
| Divalproex Sodium | 498 | $7,622 |
Prescribing Profile
Patient Profile
78
Avg Age
58%
Female
2.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About